United Therapeutics Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 9.47, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the first quarter 2026. Average collection period, for United Therapeutics's accounts receivable remained unchanged at 39 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 113 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1134, from overall ranking in the fourth quarter 2025 at 2052.

What is Receivable Turnover Ratio?
What is United Therapeutics Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

UTHR Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-3.11 %	25.38 %	-12.9 %	30.48 %	4.78 %
Y / Y Revenue Change	-1.62 %	7.38 %	6.76 %	11.71 %	17.22 %
Receivable Turnover Ratio (TTM)	9.47	9.44	9.79	9.31	9.71
UTHR's Total Ranking	# 1134	# 2052	# 2148	# 1132	# 1301
Accounts Receivable average collection period days	39	39	37	39	38
Seq. Receivable Change	-10.91 %	17.64 %	-21.51 %	17.8 %	15.29 %
Seq. Revenue Change	-1.1 %	-1.16 %	0.11 %	0.53 %	7.95 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 43
Healthcare Sector	# 114
Overall Market	# 1134

Receivable Turnover Ratio Statistics
High	Average	Low
10.43	8.69	6.75
(Mar 31 2023)		(Mar 31 2018)

UTHR Company Profile • Back to UTHR Efficiency Comparisons • Compare UTHR Receivables Turnover Ratio to its Competitors

Financial Statements
United Therapeutics's Accounts Receivable	$ 312 Millions	Visit UTHR's Balance sheet
United Therapeutics's Sales TTM	$ 3,170 Millions	Visit UTHR's Income Statement
Sources of UTHR's Revenues		Visit UTHR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
UTHR's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
UTHR's Growth Rates	UTHR's Roa	UTHR's Inventory Turnover Ratio	UTHR's Dividend Comparisons
UTHR's Profitability Ratios	UTHR's Roi	UTHR's Asset Turnover Ratio	UTHR's Dividend Growth
UTHR's Valuation Ratios	UTHR's Roe	UTHR's Financial Strength Ratios	UTHR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Cv Sciences Inc	27.37	$ 11.925 Millions	$ 0.436 Millions
Wave Life Sciences Ltd	27.36	$ 88.173 Millions	$ 3.223 Millions
Safe Pro Group Inc	27.29	$ 1.642 Millions	$ 0.060 Millions
Atara Biotherapeutics Inc	27.03	$ 23.540 Millions	$ 0.871 Millions
Biorestorative Therapies Inc	25.41	$ 0.363 Millions	$ 0.014 Millions
Jaguar Health Inc	24.65	$ 29.569 Millions	$ 1.200 Millions
Kiniksa Pharmaceuticals International Plc	24.63	$ 754.045 Millions	$ 30.618 Millions
Polomar Health Services, Inc.	24.47	$ 1.649 Millions	$ 0.067 Millions
Agenus Inc	24.33	$ 123.866 Millions	$ 5.091 Millions
Igc Pharma Inc	23.44	$ 1.166 Millions	$ 0.050 Millions
Cytomx Therapeutics Inc	23.09	$ 35.542 Millions	$ 1.539 Millions
Siga Technologies Inc	22.41	$ 93.777 Millions	$ 4.186 Millions
Lipocine Inc	22.09	$ 2.002 Millions	$ 0.091 Millions
Fonar Corporation	21.15	$ 105.338 Millions	$ 4.981 Millions
Neuraxis Inc	20.94	$ 4.282 Millions	$ 0.204 Millions
Vystar Corporation	20.58	$ 0.048 Millions	$ 0.002 Millions
Lifemd Inc	19.91	$ 177.869 Millions	$ 8.934 Millions
Longeveron Inc	19.07	$ 1.216 Millions	$ 0.064 Millions
Sonida Senior Living Inc	18.82	$ 411.850 Millions	$ 21.878 Millions
Nutriband Inc	16.79	$ 1.803 Millions	$ 0.107 Millions
Bioadaptives Inc	16.64	$ 0.024 Millions	$ 0.001 Millions
Premier Air Charter Holdings Inc	16.33	$ 33.205 Millions	$ 2.033 Millions
Bioage Labs Inc	15.90	$ 10.316 Millions	$ 0.649 Millions
Escalon Medical Corp	15.15	$ 11.445 Millions	$ 0.756 Millions
Nurix Therapeutics Inc	15.11	$ 71.779 Millions	$ 4.750 Millions
Rosecliff Acquisition Corp I	15.05	$ 23.433 Millions	$ 1.557 Millions
Lexicon Pharmaceuticals Inc	14.91	$ 69.643 Millions	$ 4.670 Millions
Qhslab Inc	14.80	$ 2.775 Millions	$ 0.188 Millions
Nexgel Inc	14.19	$ 10.382 Millions	$ 0.732 Millions
Sutro Biopharma Inc	14.04	$ 99.608 Millions	$ 7.095 Millions

Date modified: 2026-08-29T17:17:23+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.